Consortia

Consortia

Consortia such as INNODIA, INNODIA HARVEST, and EDENT1FI provide immense value to the type 1 diabetes field, spanning efforts from population screening and biomarker discovery to deeper insights into disease pathogenesis and the development of targeted clinical trials. These collaborative efforts are successfully driven by the managerial leadership of Dr. Chantal Mathieu, whose ability to coordinate large-scale research initiatives and bring together the right people across disciplines has been instrumental in accelerating progress.

Consortia projects

Overview of all projects
8/15/2025
-
8/15/2030
INNODIA Early T1D Detection

Promotors:

Chantal Mathieu

11/1/2023
-
10/31/2028
European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception. (EDENT1FI)

Promotors:

Chantal Mathieu

12/1/2022
-
11/30/2023
European pre-T1D Registry. (PRET1DREG)

Promotors:

Chantal Mathieu

5/1/2020
-
4/30/2024
Translational approaches to disease-modifying therapy of type 1 diabetes: HARVESTing the fruits of INNODIA. (INNODIA HARVEST)

Promotors:

Chantal Mathieu

11/1/2015
-
10/31/2023
Translational approaches to disease-modifying therapy of type 1 diabetes: An innovative approach towards understanding and arresting type 1 diabetes. (INNODIA)

Promotors:

Chantal Mathieu

11/1/2009
-
4/30/2015
Natural Immune Modulation for Intervention in Type 1 Diabetes (NAIMIT)

Promotors:

Chantal Mathieu

Support us

Choose to make a direct impact by contributing to a specific research project or by supporting the overarching goals of the Hippo & Friends Type 1 Diabetes Fund. 

By donating today, you enable early-career scientists to pursue groundbreaking research aimed at preventing and curing type 1 diabetes.
Every contribution moves us one step closer to breakthroughs that matter.

I want to make a direct donationI want to support Hippo & Friends

Other research lines